Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(19/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(19/week)
News
United States
(559/week)
Manufacturing
(388/week)
Energy
(305/week)
Technology
(408/week)
Other Energy
(276/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Phenytoin
Jul 29, 2019
Epygenix Therapeutics Receives IND Approval of EPX-100 for the Treatment of Dravet Syndrome
Jul 25, 2019
ADVANZ PHARMA Corp. Comments on CMA Statement of Objections Related to Nitrofurantoin
Oct 24, 2018
Eisai and Oklahoma Health Care Authority Enter Value-Based Agreement for FYCOMPA
Sep 28, 2018
Eisai Announces FDA Approval Of FYCOMPA® in Pediatric Patients As Young As 4 Years Old For The Treatment Of Partial-Onset Seizures
Aug 23, 2018
FDA approves DIACOMIT (Stiripentol) for the treatment of seizures associated with Dravet syndrome (DS) in patients 2 years of age and older taking clobazam
May 30, 2018
Eisai Receives FDA Priority Review Designation for FYCOMPA® (perampanel) CIII Pediatric Indications Supplemental New Drug Application (sNDA)
Apr 19, 2018
Eisai presentations at the Annual Meeting of the American Academy of Neurology highlight key data supporting real-world retention rates and long-term seizure-freedom rates with FYCOMPA
Mar 30, 2018
Eisai Submits Supplemental New Drug Application (sNDA) to FDA for FYCOMPA® (perampanel) Pediatric Indications
Feb 05, 2018
Embrace by Empatica is the world's first smart watch to be cleared by FDA for use in Neurology
Nov 22, 2017
Eisai Announces Presentations on Perampanel (marketed as FYCOMPA CIII) at the Annual Meeting of the American Epilepsy Society (AES)
Nov 06, 2017
UCB's VIMPAT® (lacosamide) now approved by FDA to treat partial-onset seizures in pediatric epilepsy patients
Sep 15, 2017
New indication for BRIVIACT® (brivaracetam): UCB's newest antiepileptic drug approved by FDA as monotherapy treatment of partial-onset seizures in adults
Aug 23, 2017
Epygenix Therapeutics Receives US FDA Orphan Drug Designation for EPX-300 for the Treatment of Patients With Dravet Syndrome
Jul 26, 2017
FDA Approves Eisai's FYCOMPA® (perampanel) for Use as Monotherapy for the Treatment of Partial-Onset Seizures
Latest News
May 16, 2024
Sulfur Hexafluoride (SF6) Global Strategic Industry Report 2024: Market to Reach $357 Million by 2030 from $...
May 15, 2024
Phison Introduces PASCARI Brand and Launches X200 SSD for Enterprise Market
May 15, 2024
Ross Buchmueller appointed to the USAA Board of Directors
May 15, 2024
High resolution automatic methane emissions detection in satellite data using AI
May 15, 2024
BAE Systems to Develop Next-Generation Airborne Decoy Countermeasure
May 15, 2024
Tavant Launches New Pricing Analytics Module for its AI-powered Enterprise Analytics Platform (TMAP)
May 15, 2024
Message Broadcast Strengthens Executive Leadership Team with Key Hires
May 15, 2024
Avangrid Named Handshake Early Talent Award Winner
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events